Pope Francis slept well during a quiet first night in the hospital after being admitted with a respiratory tract infection, ...
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
Management targets JPY 65 billion-JPY 75 billion in capital expenditure per year over the medium term. We think its operating cash flow could support such a level of investments, but the dividend ...
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...
On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...
Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...
More than 2 million donuts have been recalled due to Listeria risk—but many were sold under private-label brands like Dunkin' ...
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
One innovative solution that has been steadily gaining momentum is the launch of private-label supplements. This strategy not only offers a pathway to higher profit margins but also enables brands to ...
Leveraging the power of private label supplements europe opens up opportunities to build a strong brand presence while tapping into a diverse and growing consumer base. Europe’s market is not only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback